Finds why heart clot treatment may not work
Part of Heart & circulation clinical trials.
This study looks at people with a specific type of heart attack who received clot-busting treatment before reaching the hospital. It aims to figure out what predicts why the treatment might fail, which could help improve care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You had a heart attack called STEMI
- You received thrombolysis (clot-busting medicine) before arriving at the hospital
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special device that sucks out blood clots during a heart attack is better than standard care for reducing clot size before placing a stent. It may help patients who have a large clot and a blocked artery.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This trial tests whether an AI-powered app can help doctors give clot-busting medicine earlier to people having a severe heart attack (STEMI) when immediate angioplasty isn't possible. If you can't get a procedure within 2 hours, this treatment might be an option.
This study looks at whether a simple blood test (triglyceride glucose index) can help predict how well blocked heart arteries are opened after a heart attack treated with emergency angioplasty. It may help doctors better understand recovery and future risks.
This trial tests a new approach to treating blood clots during a heart attack to prevent damage to the small blood vessels in your heart. You would receive this treatment during an emergency catheterization procedure if you have signs of a major heart attack.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Hear when a new STEMI - ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.